Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (21)
Julian D. Gillmore
University College London, National Amyloidosis Centre, Royal Free Hospital, London
Ed Gane
University of Auckland, Auckland, New Zealand
Jörg Täubel
Richmond Pharmacology, London
Björn Pilebro
Umeå University, Umeå, Sweden
Andoni Echaniz-Laguna
Bicêtre University Hospital, Assistance Publique–Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France
Justin Kao
Auckland City Hospital, Auckland, New Zealand
William Litchy
Mayo Clinic, Rochester, MN
Safi Shahda
Intellia Therapeutics, Cambridge, MA
Alexandra Haagensen
Intellia Therapeutics, Cambridge, MA
Liron Walsh
Intellia Therapeutics, Cambridge, MA
Derek Smith
Intellia Therapeutics, Cambridge, MA
Jessica Kachadourian
Intellia Therapeutics, Cambridge, MA
Jonathan H. Ward
Intellia Therapeutics, Cambridge, MA
David Lebwohl
Intellia Therapeutics, Cambridge, MA
Peijuan Zhu
Intellia Therapeutics, Cambridge, MA
Yuanxin Xu
Intellia Therapeutics, Cambridge, MA
Adia Leung
Intellia Therapeutics, Cambridge, MA
Alison Sonderfan
Intellia Therapeutics, Cambridge, MA
David E. Gutstein
Regeneron Pharmaceuticals, Tarrytown, NY
Garen Manvelian
Regeneron Pharmaceuticals, Tarrytown, NY
David Adams
Bicêtre University Hospital, Assistance Publique–Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France